Search

Your search keyword '"Forconi, F."' showing total 326 results

Search Constraints

Start Over You searched for: Author "Forconi, F." Remove constraint Author: "Forconi, F."
326 results on '"Forconi, F."'

Search Results

301. Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia.

302. Massive intravascular hemolysis: a fatal complication of Clostridium perfringens septicemia in a patient with acute lymphoblastic leukemia.

303. Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma.

304. Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial.

305. Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies.

306. Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch.

307. Molecular cytogenetic analysis of B-CLL patients with aggressive disease.

308. Trisomy 12 and t(14;22)(q32;q11) in a patient with B-cell chronic lymphocytic leukemia.

309. Towards the pharmacotherapy of hairy cell leukaemia.

311. Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency.

312. Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders.

313. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.

314. Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC).

315. Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses.

316. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events.

317. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.

318. Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing.

319. The occurrence and significance of V gene mutations in B cell-derived human malignancy.

320. Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.

321. CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland.

322. Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas.

323. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.

324. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate.

325. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.

326. 2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders.

Catalog

Books, media, physical & digital resources